- 询价
- 辰辉创聚生物®️
- 中国
- NBAB-104118
- 2026年05月21日
- ELISA(Cap)
相关产品推荐更多 >
抗Lambda Light Chain单抗 | Anti-Lambda Light Chain Monoclonal Antibody, NBAB-189901
询价抗TAK1单抗 | Anti-TAK1 Monoclonal Antibody
询价NebuSelect™ 抗Cystatin F/CST7多抗 | Anti-Cystatin F/CST7 Polyclonal Antibody
询价
抗犬 CD22多克隆抗体 | Anti-Dog CD22 Polyclonal Antibody
询价抗人PPP5C多克隆抗体 | Anti-Human PPP5C Polyclonal Antibody
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human IL-8/Interleukin-8/CXCL8 Protein
- 形态：
liquid
- 保存条件：
见COA
- 克隆性：
单克隆
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 应用范围：
ELISA(Cap)
- 抗体英文名：
Anti-IL-8/CXCL8 Monoclonal Antibody
- 抗体名：
抗IL-8/CXCL8单抗
- 规格：
100ul; 500ul; 1ml
| 产品信息
品名：NebuSelect™ Anti-IL-8/CXCL8 Monoclonal Antibody
货号：NBAB-104118
品牌：辰辉创聚生物®️
规格：100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Anti-IL-8/CXCL8 Monoclonal Antibody (CAT# NBAB-104118) was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human IL-8/Interleukin-8/CXCL8.
| 产品属性
Product Category：Mouse MAb
Reactivity：Human
Specificity：Human IL-8/CXCL8
Immunogen：Recombinant Human IL-8/Interleukin-8/CXCL8 Protein
Isotype：Monoclonal Mouse IgG1
Purification：Protein A
Buffer：0.2 μm filtered solution in PBS
Conjugate：Unconjugated
Applications：ELISA(Cap)
Dilution：0
Storage：This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.
For Research Use Only!
To get more information, please contact us freely.
郑重声明：仅用于科学研究，不可用于诊断或治疗。
更多产品细节，请联系我司相关客服人员。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Production of Monoclonal Antibody by DNA Immunization with Electroporation
DNA immunization with in vivo electroporation is an efficient alternative protocol for the production of monoclonal antibodies (mAb). Generation of mAb by DNA immunization is a novel approach to circumvent the following technical hurdles
Immunohistochemistry: Fluorescence Protocol 2.0
that have been harvested, fixed and permeabilized at the peak of cytokine production after in vitro stimulation with strong polyclonal activators such as phorbol 12-myristate 13 acetate/ionomycin, anti-CD3+ CD28 monoclonal antibody, LPS or bacterial superantigens
1, 2. Their main advantage over monoclonal antibo-dies is their resistance to denaturation and degradation.Being very robust and easy to synthesize, they are becoming widely used for the development of aptamer- based biosensors in the diagnost-ics field3.
技术资料暂无技术资料 索取技术资料
